Predictive value of HPSE for major adverse cardiovascular events in patients with ST-segment elevation myocardial infarction
Coronary HPSE is an independent predictor of 6-month MACE in STEMI patients. It also enhances the predictive capability of the GRACE score. Because of this, HPSE serves as a promising biomarker that can help doctors assess risk more accurately and guide clinical decisions.
Authors
- YuHong Hu
- Qun Jin (ORCID: https://orcid.org/0000-0003-4844-6995)
- Shuai Yang (ORCID: https://orcid.org/0000-0001-8359-4032)
- Shufang Han (ORCID: https://orcid.org/0000-0001-7045-3361)
- Zhen Li (ORCID: https://orcid.org/0000-0002-0464-1791)
- Zheng Wang (ORCID: https://orcid.org/0000-0002-1176-7659)
- XueChao TANG
- Bin Li
- Zhenyu Niu
- Wenyan Liu
- Ruimin Chen
- Zonghu Jia
Institutions
- People's Liberation Army 401 Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2026-02-12
- DOI
- https://doi.org/10.3389/fcvm.2026.1743115
- Primary Topic
- Proteoglycans and glycosaminoglycans research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Weifang Medical University
- Chinese People’s Liberation Army